22 January 2024
SEED Innovations Limited
("SEED" or the "Company")
CEO Presenting at Proactive One2One Investor Forum
SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, is pleased to announce that it will be participating in the Proactive One2One Investor Forum at the Chesterfield Mayfair Hotel in London from 6 pm on Thursday 25 January 2024.
The in-person event will allow interested investors to learn more about the Company's investment opportunity, strategy, and market drivers.
The agenda includes a presentation by Ed McDermott, CEO of Seed Innovations, to be followed by a short Q&A session.
The event will also be available to view afterwards on Proactive's YouTube channel and the Company's social media: https://twitter.com/SEEDInnov
For further details and to register your attendance, please click the following link: https://www.proactiveinvestors.co.uk/register/event_details/437
-Ends-
For further information on the Company please visit: www.seedinnovations.co or contact:
Ed McDermott Lance de Jersey |
SEED Innovations Ltd |
E: info@seedinnovations.co
|
James Biddle Roland Cornish |
Beaumont Cornish Limited, Nomad |
T: (0)20 7628 3396
|
Isabella Pierre Damon Heath |
Shard Capital Partners LLP Broker |
T: (0)20 7186 9927 |
Ana Ribeiro Isabelle Morris
|
St Brides Partners Ltd, Financial PR |
E: seed@stbridespartners.co.uk |
Notes
Seed Innovations Ltd
SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.